{
  "meta": {
    "timestamp": "2025-01-06T08:53:02.699573",
    "version": "1.0",
    "type": "search_analysis"
  },
  "companies": [
    {
      "company_name": "Fulgent Genetics Inc",
      "symbol": "FLGT",
      "analysis": {
        "historical": {
          "risk_score": 65,
          "key_risks": [
            "Post-Pandemic Revenue Decline",
            "Regulatory Risks",
            "Competitive Pressures",
            "Dependence on COVID-19 Testing",
            "Data Privacy Concerns"
          ],
          "controversies": [
            "Heavy reliance on COVID-19 testing revenue",
            "Potential data privacy breaches due to sensitive genetic data handling"
          ],
          "environmental_issues": [],
          "social_issues": [
            "Data privacy and ethical concerns related to genetic testing"
          ],
          "governance_issues": [
            "Navigating evolving regulatory landscapes in international markets"
          ],
          "recommendation": "caution",
          "confidence_score": 80
        },
        "evidence": {
          "sources": [
            {
              "url": "",
              "title": "2022 ESG Report 2022 ESG Report T - ir.fulgentgenetics.com",
              "snippet": "test menu while maintaining accessible pricing, high accuracy, and competitive turnaround times. Since the launch of our first commercial genetics tests, focused on rare pediatric diseases in 2013, Fulgent's capabilities have rapidly grown into an unrivaled offering of more than 18,400+ single gene tests, 900+ disease tests, whole genome",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Fulgent Genetics Inc Fulgent Genetics Inc regulatory risks genetic testing",
              "retrieved_at": "2025-01-06T15:52:35.078642+00:00",
              "published_date": null,
              "source_hash": "730a8a359c3544adb68813e02fbd863d"
            },
            {
              "url": "",
              "title": "Fulgent Genetics, Inc. ESG Risk Rating - Sustainalytics",
              "snippet": "Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Fulgent Genetics Inc Fulgent Genetics Inc regulatory risks genetic testing",
              "retrieved_at": "2025-01-06T15:52:35.078761+00:00",
              "published_date": null,
              "source_hash": "6a883055577e75d2c1a193a2e999e84b"
            },
            {
              "url": "",
              "title": "August 4, 2023 - Fulgent Genetics",
              "snippet": "Genetics, Inc. (the \"Company\") about future events based on current views and assumptions. Examples of forwardlooking statement- s made in this presentation include, among others, those related to long-term upside or value, management of risk, anticipated growth and positioning, addressable market e stimates, the Company's mission, vision and",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Fulgent Genetics Inc Fulgent Genetics Inc regulatory risks genetic testing",
              "retrieved_at": "2025-01-06T15:52:35.078780+00:00",
              "published_date": null,
              "source_hash": "387c0c1f81921884052741c1d1693bdb"
            },
            {
              "url": "",
              "title": "flgt-10k_20211231.htm - SEC.gov",
              "snippet": "Fulgent Genetics, Inc., together with its subsidiaries and an affiliated professional corporation with which the Company has a management services arrangement, are collectively referred to in this Annual Report on Form 10-K as the \"Company,\" \"Fulgent,\" \"we,\" \"us,\" and \"our.\" ... We believe widespread genetic testing could ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Fulgent Genetics Inc Fulgent Genetics Inc regulatory risks genetic testing",
              "retrieved_at": "2025-01-06T15:52:35.078795+00:00",
              "published_date": null,
              "source_hash": "bfdb43bfa6489d997df83f58a042aa3c"
            },
            {
              "url": "",
              "title": "Fulgent Genetics, Inc. (Form: 10-K, Received: 03/13/2020 06:07:25)",
              "snippet": "The study retrospectively evaluated 475 individuals with a personal or family history of cancer who had undergone a clinically indicated multi-gene panel test of six to 110 genes from one of the following six commercial laboratories: Myriad Genetics (n=354), Ambry Genetics (n=100), Fulgent (n=17), University of Washington Genetics Laboratory (n ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Fulgent Genetics Inc Fulgent Genetics Inc regulatory risks genetic testing",
              "retrieved_at": "2025-01-06T15:52:35.078808+00:00",
              "published_date": null,
              "source_hash": "820c1c26fb28be24ac43aaee940d4182"
            },
            {
              "url": "",
              "title": "Securities Fraud Claims on Behalf of Fulgent Genetics, Inc. | Edelson ...",
              "snippet": "Background on the Fulgent Genetics, Inc. Securities Class Action. Fulgent is a full-service genomic testing company build around a foundational technology platform. Fulgent has a diverse testing menu and is focused on transforming patient care in oncology, anatomic pathology, infectious diseases, and reproductive health.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Fulgent Genetics Inc Fulgent Genetics Inc data privacy breaches",
              "retrieved_at": "2025-01-06T15:52:39.118697+00:00",
              "published_date": null,
              "source_hash": "e9f773e094eb107f3b0fd8113c368221"
            },
            {
              "url": "",
              "title": "SHAREHOLDER ALERT: Fulgent Genetics (FLGT) Officers and Directors Under ...",
              "snippet": "Fulgent provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients. Fulgent and three of its executive officers are currently subject to a class action ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Fulgent Genetics Inc Fulgent Genetics Inc regulatory risks genetic testing",
              "retrieved_at": "2025-01-06T15:52:35.078835+00:00",
              "published_date": null,
              "source_hash": "3ab300e363c296f4e32d62969b5c467b"
            },
            {
              "url": "",
              "title": "Fulgent Genetics Awarded Contract by the U.S. Department of Veterans ...",
              "snippet": "EL MONTE, Calif., October 31, 2024--Fulgent Genetics, Inc. (NASDAQ: FLGT) (\"Fulgent,\" or the \"Company\"), a technology-based company with a well-established laboratory services business and a ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Fulgent Genetics Inc Fulgent Genetics Inc regulatory risks genetic testing",
              "retrieved_at": "2025-01-06T15:52:35.078847+00:00",
              "published_date": null,
              "source_hash": "8dc7c5f84503bcec407de8d721f61c2a"
            },
            {
              "url": "",
              "title": "Fulgent Genetics: A Value Stock With Caveats (Rating Downgrade)",
              "snippet": "Today, we revisit diagnostic testing concern Fulgent Genetics, Inc., which is currently navigating through the \"COVID-19 cliff\". Revenue growth should return in FY2025, and the company is sitting ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Fulgent Genetics Inc Fulgent Genetics Inc post-pandemic revenue decline",
              "retrieved_at": "2025-01-06T15:52:45.725336+00:00",
              "published_date": "2024-12-18T15:35:00+00:00",
              "source_hash": "8489ae27d5923f747d74ca00405427ba"
            },
            {
              "url": "",
              "title": "Fulgent Genetics: High Insider Ownership Supports Asymmetric Upside",
              "snippet": "Fulgent Genetics (NASDAQ:FLGT) is a biotech company, focused on diagnostics such as cancer screening tests. They had a successful COVID-19 test segment that led to 3 years of profits.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Fulgent Genetics Inc Fulgent Genetics Inc regulatory risks genetic testing",
              "retrieved_at": "2025-01-06T15:52:35.078868+00:00",
              "published_date": null,
              "source_hash": "96acebb004cc19fbe1fcad499989f3a3"
            },
            {
              "url": "",
              "title": "Fulgent Genetics: A Value Stock With Caveats (Rating Downgrade)",
              "snippet": "Today, we revisit diagnostic testing concern Fulgent Genetics, Inc., which is currently navigating ... consists of molecular diagnostic testing; genetic testing; anatomic pathology laboratory ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Fulgent Genetics Inc Fulgent Genetics Inc regulatory risks genetic testing",
              "retrieved_at": "2025-01-06T15:52:37.635399+00:00",
              "published_date": "2024-12-18T15:35:00+00:00",
              "source_hash": "d6184a2ee9471fa06438a317d68a1c1f"
            },
            {
              "url": "",
              "title": "Fulgent Genetics: High Insider Ownership Supports Asymmetric Upside",
              "snippet": "Fulgent Genetics is a biotech company with a profitable COVID-19 diagnostics segment that will be negligible going forward. Read why I rate FLGT stock a Buy.",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Fulgent Genetics Inc Fulgent Genetics Inc regulatory risks genetic testing",
              "retrieved_at": "2025-01-06T15:52:37.635488+00:00",
              "published_date": "2024-12-24T05:24:00+00:00",
              "source_hash": "16e4f9514502b1e8e8b57aa9035055f4"
            },
            {
              "url": "",
              "title": "Fulgent Genetics, Inc. (NASDAQ:FLGT) Q3 2024 Earnings Call Transcript",
              "snippet": "Fulgent Genetics, Inc. (NASDAQ:FLGT) Q3 2024 Earnings Call ... As a result, matters discussed in any forward-looking statements are subject to risks, uncertainties and changes in circumstances ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Fulgent Genetics Inc Fulgent Genetics Inc regulatory risks genetic testing",
              "retrieved_at": "2025-01-06T15:52:37.635519+00:00",
              "published_date": "2024-12-10T23:36:00+00:00",
              "source_hash": "720bbcc3f98217129af9f4ae5727e402"
            },
            {
              "url": "",
              "title": "Barclays PLC Has $3.80 Million Holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT)",
              "snippet": "Barclays PLC boosted its holdings in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 22.6% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC).",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Fulgent Genetics Inc Fulgent Genetics Inc data privacy breaches",
              "retrieved_at": "2025-01-06T15:52:41.627661+00:00",
              "published_date": "2024-12-23T07:55:00+00:00",
              "source_hash": "d74c4f56f42400051d4eb3781a9f3621"
            },
            {
              "url": "",
              "title": "Fulgent Genetics, Inc. (FLGT): Among the Best Genomics Stocks to Buy Right Now",
              "snippet": "(see more details here) Fulgent Genetics, Inc. (NASDAQ:FLGT) is a technology company that specializes in genetic testing and provides clinicians with clinically meaningful diagnostic information.",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Fulgent Genetics Inc Fulgent Genetics Inc regulatory risks genetic testing",
              "retrieved_at": "2025-01-06T15:52:37.635571+00:00",
              "published_date": "2024-12-16T03:15:00+00:00",
              "source_hash": "a003d6b139566f47bb113c582a6e5094"
            },
            {
              "url": "",
              "title": "HIPAA Notice of Privacy Practices - Fulgent Genetics",
              "snippet": "Fulgent Genetics, Inc. (\"Company\" or \"we\" or \"us\") is required by law to provide individuals with notice of its legal duties and privacy practices with respect your \"Protected Health Information\" (\"PHI\") (defined below). This Notice describes the privacy practices of Fulgent, its employees, and other personnel with respect to PHI.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Fulgent Genetics Inc Fulgent Genetics Inc data privacy breaches",
              "retrieved_at": "2025-01-06T15:52:39.118620+00:00",
              "published_date": null,
              "source_hash": "25ca37d0569fc9425a4fc35e45283018"
            },
            {
              "url": "",
              "title": "Privacy Policy - Fulgent Genetics",
              "snippet": "Fulgent Genetics, Inc. (\"Fulgent,\" \"we\" or \"us\") is committed to protecting your privacy. ... Our analytics partners do not create individual profiles for visitors and only collect aggregate data. To learn more about privacy of our analytics partners, please consult information provided by such analytics partners. ... or destroyed ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Fulgent Genetics Inc Fulgent Genetics Inc data privacy breaches",
              "retrieved_at": "2025-01-06T15:52:39.118677+00:00",
              "published_date": null,
              "source_hash": "a780e5edcb5a32fe7e4d303420061324"
            },
            {
              "url": "",
              "title": "Picture Genetics | HIPAA Notice of Privacy Practices",
              "snippet": "Information breach notification. We are required to notify you following the discovery of a breach of unsecured Protected Health Information, unless there is a demonstration, based on a risk assessment, that there is a \"low probability\" that the Protected Health Information has been compromised. ... c/o Fulgent Genetics, Inc. Attention ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Fulgent Genetics Inc Fulgent Genetics Inc data privacy breaches",
              "retrieved_at": "2025-01-06T15:52:39.118685+00:00",
              "published_date": null,
              "source_hash": "a3826848a0e0f1dc0a00080807d0714e"
            },
            {
              "url": "",
              "title": "flgt-10k_20211231.htm - SEC.gov",
              "snippet": "FULGENT GENETICS, INC. (Exact name of registrant as specified in its charter) ... Congress has also been considering similar federal legislation relating to data privacy and data protection. The FTC and states' Attorneys General have also brought enforcement actions and prosecuted some data breach cases as unfair and/or deceptive acts or ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Fulgent Genetics Inc Fulgent Genetics Inc data privacy breaches",
              "retrieved_at": "2025-01-06T15:52:39.118691+00:00",
              "published_date": null,
              "source_hash": "463a413bf0e9ca887829a33eb14099bb"
            },
            {
              "url": "",
              "title": "SHAREHOLDER ALERT: Fulgent Genetics (FLGT) Officers ... - Markets Insider",
              "snippet": "SAN FRANCISCO, Nov. 8, 2022 /PRNewswire/ -- ASchubert Jonckheer & Kolbe LLP is investigating potential derivative claims on behalf of shareholders...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Fulgent Genetics Inc Fulgent Genetics Inc data privacy breaches",
              "retrieved_at": "2025-01-06T15:52:39.118702+00:00",
              "published_date": null,
              "source_hash": "20ed986a2edb81c0f6a0ae8f5f738dae"
            },
            {
              "url": "",
              "title": "Fulgent Genetics, Inc. (Form: 10-K, Received: 03/13/2020 06:07:25)",
              "snippet": "FULGENT GENETICS, INC. (Exact name of registrant as specified in its charter) Delaware 81-2621304 ... In addition to data breach notification laws, some states have enacted statutes and rules requiring businesses to reasonably protect certain types of personal information they hold or to otherwise comply with certain specified data security ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Fulgent Genetics Inc Fulgent Genetics Inc data privacy breaches",
              "retrieved_at": "2025-01-06T15:52:39.118708+00:00",
              "published_date": null,
              "source_hash": "9e1a3a4e7d515118b24901e71e004391"
            },
            {
              "url": "",
              "title": "Privacy Policy | Fulgent Genetics",
              "snippet": "Fulgent Genetics, Inc. (\"Fulgent,\" \"we\" or \"us\") is committed to protecting your privacy. ... Los Angeles County) rather than directly through us, you may receive privacy information that is specific to the services arrangement (\"Specific Notice\") in which case we will follow the requirements in the Specific Notice.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Fulgent Genetics Inc Fulgent Genetics Inc data privacy breaches",
              "retrieved_at": "2025-01-06T15:52:39.118713+00:00",
              "published_date": null,
              "source_hash": "718aec2283a06ae90c183dffe984a8a8"
            },
            {
              "url": "",
              "title": "Fulgent Genetics, Inc. Company Profile - Dun & Bradstreet",
              "snippet": "Find company research, competitor information, contact details & financial data for Fulgent Genetics, Inc. of El Monte, CA. Get the latest business insights from Dun & Bradstreet.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Fulgent Genetics Inc Fulgent Genetics Inc data privacy breaches",
              "retrieved_at": "2025-01-06T15:52:39.118718+00:00",
              "published_date": null,
              "source_hash": "e2b1ed8f45747bcfa272c9ee8a25ed05"
            },
            {
              "url": "",
              "title": "An Authoritative Look at the Fulgent Genetics, Inc. Class Action Lawsuit",
              "snippet": "The Fulgent Genetics class action lawsuit seeks to represent purchasers or acquirers of Fulgent Genetics, Inc. (NASDAQ: FLGT) securities between March 22, 2019 and August 4, 2022, inclusive (the \"Class Period\").The Fulgent Genetics class action lawsuit - captioned Pugley v.Fulgent Genetics, Inc., No. 22-cv-06764 (C.D. Cal.) - charges Fulgent Genetics and certain of its top executives ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Fulgent Genetics Inc Fulgent Genetics Inc data privacy breaches",
              "retrieved_at": "2025-01-06T15:52:39.118723+00:00",
              "published_date": null,
              "source_hash": "758423b0aae58ca8a3c8bf87e48f273f"
            },
            {
              "url": "",
              "title": "FLGT Fulgent Genetics, Inc.",
              "snippet": "View Fulgent Genetics, Inc. (FLGT) current and estimated P/E ratio data provided by Seeking Alpha.",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Fulgent Genetics Inc Fulgent Genetics Inc post-pandemic revenue decline",
              "retrieved_at": "2025-01-06T15:52:45.725516+00:00",
              "published_date": "2024-12-27T16:01:00+00:00",
              "source_hash": "47069517fbbad391e187b5ecfa21dffa"
            },
            {
              "url": "",
              "title": "With 54% ownership, Fulgent Genetics, Inc. (NASDAQ:FLGT) boasts of strong institutional backing",
              "snippet": "To get a sense of who is truly in control of Fulgent Genetics, Inc. (NASDAQ:FLGT), it is important ... While it makes sense to study institutional ownership data for a company, it also makes ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Fulgent Genetics Inc Fulgent Genetics Inc data privacy breaches",
              "retrieved_at": "2025-01-06T15:52:41.627687+00:00",
              "published_date": "2024-12-21T08:09:00+00:00",
              "source_hash": "ddffa0fddedb128153c83f8e13ec0720"
            },
            {
              "url": "",
              "title": "12,502 Shares in Fulgent Genetics, Inc. (NASDAQ:FLGT) Bought by Intech Investment Management LLC",
              "snippet": "Fulgent Genetics, Inc. has a 52-week low of $16.56 and a 52-week high of $30.68. Insider Activity In other news, CEO Ming Hsieh sold 2,227 shares of the company's stock in a transaction dated ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Fulgent Genetics Inc Fulgent Genetics Inc data privacy breaches",
              "retrieved_at": "2025-01-06T15:52:41.627709+00:00",
              "published_date": "2024-12-05T00:00:00+00:00",
              "source_hash": "5a0fde49b9f485a0f73cb079e86719c2"
            },
            {
              "url": "",
              "title": "Announces Third Quarter 2022 Earnings and ... - Fulgent Genetics",
              "snippet": "Fulgent Pharma and Fulgent Genetics combined entity positioned to unlock significant long-term upside for both the therapeutics and diagnostic businesses while effectively managing risk. Fulgent Genetics + Fulgent Pharma History. 5. 2011. Fulgent Therapeutics founded as combined pharma and genetics company focused on oncology. 2017. 2018. 2019 ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Fulgent Genetics Inc Fulgent Genetics Inc post-pandemic revenue decline",
              "retrieved_at": "2025-01-06T15:52:43.085942+00:00",
              "published_date": null,
              "source_hash": "326ebcfc43df391b2398e0ab72b7cc4b"
            },
            {
              "url": "",
              "title": "FLGT | Fulgent Genetics Inc. Financial Statements - WSJ",
              "snippet": "Fulgent Genetics Inc. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. ... Sales or Revenue: 289.21 M: Sales or Revenue Growth-53.27%: EBITDA-43.54 M: Balance ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Fulgent Genetics Inc Fulgent Genetics Inc post-pandemic revenue decline",
              "retrieved_at": "2025-01-06T15:52:43.086070+00:00",
              "published_date": null,
              "source_hash": "eda75b890716ca97717fe12f397e69e9"
            },
            {
              "url": "",
              "title": "Fulgent Reports Third Quarter 2024 Financial Results",
              "snippet": "Total Revenue of $71.7 million; Core Revenue grows 9% year-over-year to $71.7 million; Reiterates Full Year 2024 Core Revenue Guidance of $280 million, Improves Earnings Per Share Guidance for 2024 ; EL MONTE, Calif.--(BUSINESS WIRE)--Nov. 8, 2024-- Fulgent Genetics, Inc. (NASDAQ: FLGT) (\"Fulgent,\" or the \"Company\"), a technology-based company with a well-established laboratory ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Fulgent Genetics Inc Fulgent Genetics Inc post-pandemic revenue decline",
              "retrieved_at": "2025-01-06T15:52:43.086082+00:00",
              "published_date": null,
              "source_hash": "6218c6aa808314da2fa7852c8d3df5ce"
            },
            {
              "url": "",
              "title": "2022 ESG Report 2022 ESG Report T - ir.fulgentgenetics.com",
              "snippet": "This is the inaugural ESG Report published by Fulgent Genetics, Inc. We are proud to tell our corporate story, demonstrate the impact of our ESG efforts, and build upon our ... anticipated future revenue and guidance, evaluations and judgments regarding the Company's business, products, technologies, plans regarding development and launch of ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Fulgent Genetics Inc Fulgent Genetics Inc post-pandemic revenue decline",
              "retrieved_at": "2025-01-06T15:52:43.086096+00:00",
              "published_date": null,
              "source_hash": "9aa072420f568ca312fb38b510df80b2"
            },
            {
              "url": "",
              "title": "Fulgent Genetics, Inc. (FLGT) Surpasses Q3 Earnings and Revenue ...",
              "snippet": "Fulgent Genetics (FLGT) delivered earnings and revenue surprises of 263.16% and 0.46%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Fulgent Genetics Inc Fulgent Genetics Inc post-pandemic revenue decline",
              "retrieved_at": "2025-01-06T15:52:43.086107+00:00",
              "published_date": null,
              "source_hash": "8e95b3bd94695e6358f11c052bedbf96"
            },
            {
              "url": "",
              "title": "Fulgent Genetics, Inc. (FLGT) Q2 2022 Earnings Call Transcript",
              "snippet": "10 stocks we like better than Fulgent Genetics, Inc. ... The decline in the test volume and the revenue is directly tied to the slowdown in COVID-19 testing, which came down materially relative to ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Fulgent Genetics Inc Fulgent Genetics Inc post-pandemic revenue decline",
              "retrieved_at": "2025-01-06T15:52:43.086118+00:00",
              "published_date": null,
              "source_hash": "b7e2f0734af9fcb10f2a8b2e17ecc186"
            },
            {
              "url": "",
              "title": "Fulgent Genetics, Inc. Company Profile - Dun & Bradstreet",
              "snippet": "Find company research, competitor information, contact details & financial data for Fulgent Genetics, Inc. of El Monte, CA. Get the latest business insights from Dun & Bradstreet. Fulgent Genetics, Inc. D&B Business Directory ... 2023 Revenue: $289.21. 2023 Revenue: $289.21. Actual. Cost Of Revenue: $184.76; Gross Profit: $104.46; Operating ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Fulgent Genetics Inc Fulgent Genetics Inc post-pandemic revenue decline",
              "retrieved_at": "2025-01-06T15:52:43.086128+00:00",
              "published_date": null,
              "source_hash": "9d3c31570f7d8130988ab2adee5bb387"
            },
            {
              "url": "",
              "title": "Fulgent Genetics Seeks Post-Pandemic Growth - TheStreet",
              "snippet": "Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Fulgent Genetics Inc Fulgent Genetics Inc post-pandemic revenue decline",
              "retrieved_at": "2025-01-06T15:52:43.086138+00:00",
              "published_date": null,
              "source_hash": "e6d832c3b632df70ce58150556f767ad"
            },
            {
              "url": "",
              "title": "Fulgent Genetics, Inc. (FLGT) - Yahoo Finance",
              "snippet": "Fulgent Genetics Inc (FLGT) Q3 2024 Earnings Call Highlights: Strategic Growth Amid Revenue Decline GuruFocus.com \u2022 last month Fulgent Genetics, Inc. (FLGT) Surpasses Q3 Earnings and Revenue ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Fulgent Genetics Inc Fulgent Genetics Inc post-pandemic revenue decline",
              "retrieved_at": "2025-01-06T15:52:43.086148+00:00",
              "published_date": null,
              "source_hash": "bcdaddfebf889c8729cde3a4c5be8504"
            },
            {
              "url": "",
              "title": "Fulgent Genetics, Inc. (NASDAQ:FLGT) Q3 2024 Earnings Call Transcript",
              "snippet": "Fulgent Genetics, Inc. (NASDAQ:FLGT) Q3 2024 Earnings Call ... our results in the third quarter with $71.7 million of total revenue. Third quarter revenue of $71.7 million was driven by our ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Fulgent Genetics Inc Fulgent Genetics Inc post-pandemic revenue decline",
              "retrieved_at": "2025-01-06T15:52:45.725423+00:00",
              "published_date": "2024-12-10T23:36:00+00:00",
              "source_hash": "0875aeb5ca6b90cfc29a641061aaaaea"
            },
            {
              "url": "",
              "title": "Fulgent Genetics, Inc. (FLGT) Surpasses Q3 Earnings and Revenue Estimates",
              "snippet": "Fulgent Genetics ... Inc. (CCLD), is yet to report results for the quarter ended September 2024. The results are expected to be released on November 12. This company is expected to post quarterly ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Fulgent Genetics Inc Fulgent Genetics Inc post-pandemic revenue decline",
              "retrieved_at": "2025-01-06T15:52:45.725504+00:00",
              "published_date": "2024-11-08T14:35:00+00:00",
              "source_hash": "e621f30c8685ad8f782045a7cbd34b05"
            },
            {
              "url": "",
              "title": "With 54% ownership, Fulgent Genetics, Inc. (NASDAQ:FLGT) boasts of strong institutional backing",
              "snippet": "To get a sense of who is truly in control of Fulgent Genetics, Inc. (NASDAQ:FLGT), it is important ... NasdaqGM:FLGT Earnings and Revenue Growth December 21st 2024 Institutional investors own ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Fulgent Genetics Inc Fulgent Genetics Inc post-pandemic revenue decline",
              "retrieved_at": "2025-01-06T15:52:45.725525+00:00",
              "published_date": "2024-12-21T08:09:00+00:00",
              "source_hash": "e4bce083c3cf1213ac4c520e54d37e81"
            }
          ],
          "queries": [
            {
              "category": "financial_legal",
              "query": "Fulgent Genetics Inc regulatory risks genetic testing",
              "rationale": "Investigate potential legal and regulatory challenges in the genetic testing industry that could impact Fulgent Genetics",
              "priority": 1
            },
            {
              "category": "ethical_social",
              "query": "Fulgent Genetics Inc data privacy breaches",
              "rationale": "Examine any incidents or concerns related to data privacy and patient data handling by Fulgent Genetics",
              "priority": 2
            },
            {
              "category": "financial_legal",
              "query": "Fulgent Genetics Inc post-pandemic revenue decline",
              "rationale": "Explore the financial risks and challenges Fulgent Genetics faces due to reduced COVID-19 testing demand and its impact on revenue",
              "priority": 1
            }
          ]
        },
        "categorization": {
          "product_issues": [],
          "conduct_issues": [],
          "tags": [],
          "patterns": {}
        }
      },
      "metadata": {
        "analysis_timestamp": "2025-01-06T08:53:02.699584",
        "data_confidence": 80,
        "pattern_confidence": null
      }
    }
  ]
}